Tri Locum Partners LP Kezar Life Sciences, Inc. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.39 - $8.8 $1.51 Million - $2.08 Million	-236,189 Reduced 33.28%	473,544 $3.33 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $1.64 Million - $2.21 Million	205,391 Added 40.72%	709,733 $6.11 Million
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $1.04 Million - $3.88 Million	-226,555 Reduced 31.0%	504,342 $4.17 Million
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $19,901 - $29,657	-1,618 Reduced 0.22%	730,897 $12.1 Million
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $5.45 Million - $12.2 Million	732,515 New	732,515 $12.2 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.